FCGR2A and FCGR3A polymorphisms and clinical outcome in metastatic colorectal cancer patients treated with first-line 5-fluorouracil/folinic acid and oxaliplatin +/- cetuximab

Table 1 FCGR2A and FCGR3A genotypes in the study population

	Actual frequency of genotypes (n)	Expected frequency of genotypes (n)	Hardy-Weinberg equilibrium X ²(1 degree of freedom)	P-value
*FCGR2A*
H/H	114	118.61	0.68	0.41
H/R	261	251.78
R/R	129	133.61
*FCGR3A*
F/F	241	238.10	0.37	0.54
F/V	206	211.8
V/V	50	47.10

ISSN: 1471-2407